Serum beta-enolase in acute myocardial infarction

Area of Science:

• Biochemistry
• Cardiology
• Enzymology

Background:

• Beta-enolase is an enzyme crucial for glycolysis, present in cardiac and skeletal muscle.
• Its role in cardiovascular diseases, particularly myocardial infarction, requires further investigation.

Purpose of the Study:

• To evaluate beta-enolase as a diagnostic marker for acute myocardial infarction (AMI).
• To compare the diagnostic utility of beta-enolase with creatine kinase (CK) in cardiovascular diseases.

Main Methods:

• Serum samples from patients with AMI, angina pectoris, congestive heart failure, and idiopathic cardiomyopathy were analyzed for beta-enolase concentrations.
• Enzyme activity was measured over time following acute cardiac events.

Main Results:

• Serum beta-enolase levels were significantly elevated in patients with acute myocardial infarction.
• Beta-enolase levels did not increase in other studied cardiovascular conditions.
• Enzyme activity peaked 12-14 hours post-event and exhibited a faster rise and fall compared to creatine kinase.
• Assay demonstrated high specificity and sensitivity.

Conclusions:

• Serum beta-enolase is a highly specific and sensitive biomarker for the early diagnosis of acute myocardial infarction.
• Its rapid kinetics make it advantageous for diagnosing initial and recurrent myocardial infarctions, potentially outperforming creatine kinase, especially in milder cases.